FOUNTAIN HILLS, Ariz.,
April 21, 2011 /PRNewswire/ --
Sunridge International (OTCBB/OTCQB: SNDZ), holds the patent on a
vacuum fixation device and suction rings for the treatment of open
angle and pigmentary glaucoma worldwide. President and CEO,
G. Richard Smith is announcing an
update on a number of current developments with the company:
- Current distribution agreements
- Expansion of distribution agreements
- Company owned and operated clinics
Mr. Smith announced that, "We recently signed a new exclusive
distributor in Turkey. We
are negotiating additional agreements at the present time for
additional territories, and have received notice of large pending
orders for equipment from our current distributors.
"A Study for reimbursement approval is beginning in the
Middle East under the direction of
our exclusive distributor in that region. Once approved, this
will allow patients to receive our PNT treatment at no out of
pocket cost to them. This should provide a major revenue
source to Sunridge, in the form of equipment sales."
Mr. Smith went on to say, "Our business plan is moving forward
as anticipated. As previously announced, the company recently
decided to move forward with company owned and operated glaucoma
treatment centers, and we are actively moving forward with the
funding of our first clinic. We hope to have the funding
completed within the next 30-60 days."
Mr. Smith was recently interviewed by CEOCast.com regarding the
company, the company's proprietary device and procedure, and recent
events. That interview can be accessed on the internet by going to
www.ceocast.com
Glaucoma is the second leading cause of blindness, affecting
over 70 million people worldwide. PNT has been proven (through
studies completed over the last 10 yrs) to be a safe, effective,
non-invasive and a cost effective alternative for treatment for
glaucoma and ocular hypertension. The 2-minute treatment has been
developed, patented, and distributed by Sunridge International,
wholly owned subsidiary, Ophthalmic International
www.oi-pnt.com.
Forward Looking Statements
This press release and the statements of representatives of
Sunridge International, Inc. (the "Company") related thereto
contain, or may contain, among other things, "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. All statements, other than statements of
historical fact included herein are "forward-looking statements,"
including any other statements of non-historical information.
These forward-looking statements are subject to significant
known and unknown risks and uncertainties and are often identified
by the use of forward-looking terminology such as "projects,"
"may," "could," "would," "should," "believes," "expects,"
"anticipates," "estimates," "intends," "plans," "ultimately" or
similar expressions. All forward-looking statements involve
material assumptions, risks and uncertainties, and the expectations
contained in such statements may prove to be incorrect.
Investors should not place undue reliance on these
forward-looking statements, which speak only as of the date of this
press release. The Company's actual results could differ
materially from those anticipated in these forward-looking
statements as a result of a variety of factors, including factors
and risks discussed in the periodic reports that the Company files
with the Securities and Exchange Commission (http://www.sec.gov).
All forward-looking statements attributable to the Company or
persons acting on its behalf are expressly qualified in their
entirety by these factors. The Company undertakes no duty to
update these forward-looking statements except as required by
law.
CONTACT:
Jeff Smith, Sunridge
International
T: +1-480-837-6165
e-mail: info@sunridgeint.com
MEDIA:
Victor Webb, Marston Webb
International
T: (212) 684-6601
e-mail: marwebint@cs.com
SOURCE Sunridge International
